NCT06566313View on ClinicalTrials.gov

An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

April 30, 2024

Conditions
Transcranial Direct Current StimulationParkinson DiseasePrimary Left Motor Cortex
Interventions
BEHAVIORAL

transcranial Direct Current Stimulation

On the basis of conventional anti-PD drugs, the left M1 region (based on the C3 coordinates of EEG 10-20 system and the surrounding FC1, FC5, CP1, CP5 coordinates) was treated with cathodic tDCS. The electrical stimulation intensity was 2.0mA, the treatment time was 20min, and the treatment lasted for 10 days.

Trial Locations (1)

Unknown

Cognitive Neuropsychology Lab Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER

NCT06566313 - An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD | Biotech Hunter | Biotech Hunter